The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Worms will be used to treat coronavirus: what technologies and medicines are still used

Two French hospitals start drug-based testing hemoglobin obtained from the blood of annelids. This is stated in the video "Voices of America".

Photo: Shutterstock

The drug will help patients suffering from respiratory complications with COVID-19.

The worms have attracted the attention of scientists due to the fact that they breathe only in water and stop breathing in the sand. Scientists have found that hemoglobin in their blood is a store of oxygen, which is enough for six hours.

The developed drug has already helped dozens of patients after kidney transplant surgery. Now, doctors who treat acute respiratory distress syndrome are hoping for him.

At the first stage of testing, it will be offered to almost hopeless patients as an experimental medicine.

What methods of treatment for COVID-19 are used in the world?

In Italy, announced a positive result of the treatment of patients with coronavirus drug against rheumatoid arthritis "Tocilizumab" (Tocilizumab) manufactured by the pharmaceutical company Roche. This was the result of a scientific experiment, the protocol of which was approved at the state level. In total, already 11 patients in Naples were treated improperly with the indicated drug, and the results are impressive.

On the subject: Coronavirus leads the world to the worst crisis in 100 years: forecast of IMF chief economist

The drug acts on the complication of this virus, that is, on the inflammation that creates COVID-19. It reduces the hyperactivity of the immune system, which is the cause of respiratory failure.

Read more in our material.

Researchers from France published a statement detailing how the combination antimalarials and antibiotics can be an important weapon in the fight against coronavirus.

In early March, researchers prescribed anti-malarial hydroxychloroquine and the antibiotic azithromycin to patients, according to data published in the International Journal of Antimicrobials. Some experts, however, also call for caution regarding the combination of drugs.

The Federal Food and Drug Administration (FDA) is studying the effects of hydroxychloroquine as a potential treatment for COVID-19, but has not yet made any recommendations on it.

In a summary of their research, experts noted that patients “showed a significant reduction in viral carriage” 6 days after the start of treatment with two drugs, and “a significantly shorter average duration of carriage” compared to untreated patients.

On the subject: “Such diseases have existed before”: the doctor said why you should not panic because of coronavirus

Untreated patients were included in the study for negative control. 6 patients in the study were asymptomatic, while 22 had symptoms of an upper respiratory tract infection, 8 had symptoms of a lower respiratory tract infection. Researchers examined 20 cases.

Read more in our material.

In different states, the disease spreads at different rates. And for some reason, coronavirus infection (at least at first glance) is significantly less active in countries where children are required vaccinated against tuberculosis using BCG vaccine.

This theory is based on public statistics on coronavirus infection. Physicians involved in research say that the presence of BCG in a particular person certainly does not give him immunity from the new virus. Vaccinated patients are among severely ill patients, and among those killed by COVID-19.

At the same time, it cannot be ruled out that during a pandemic, vaccination may be useful on a national scale: in any case, preliminary data from this theory do not contradict.

Read more in our material.

According to new data based on patient observations, more than two-thirds of seriously ill patients with COVID-19 condition improved after treatment with Remdesivir, an experimental drug developed by California-based Gilead Sciences Inc.

The author of the article called the results “encouraging,” but warned that it was difficult to interpret the results because they did not include comparison with the control group, as would be the case in a randomized clinical trial. In addition, the number of patients was small, the details disclosed were limited, and the observation time was relatively short.

On the subject: All you wanted to know about coronavirus but were embarrassed to ask: WHO answers

After undergoing treatment with Remdesivir and observing for 18 days, 36 patients, or 68%, showed a significant improvement. More than half of the 30 patients who, at the time of the start of the study, were on mechanical ventilation apparatus, were able to breathe independently. 25 patients, or 47%, were discharged from the hospital. Seven patients, 13% of the total number of subjects, died.

Read more in our material.

There are a number of drugs that doctors around the world are trying to treat COVID-19. When treating patients with coronavirus, doctors focus primarily not on scientific publications or the results of clinical trials (although this is also taken into account), but on WHO recommendations and national clinical recommendations.

WHO, in its clinical advice on COVID-19, also acknowledges that "there is no evidence now to recommend any specific treatment." However, employees of the organization constantly monitor experimental methods of therapy and maintain an updated list of drugs that are used by the organization's countries - both within the framework of clinical trials and outside them.

The list of drugs that are used to combat coronavirus and the conditions for their use, see our material.

In an effort to keep its readers informed of the latest news on the situation with the coronavirus, ForumDaily gathered most recent data on infections and deaths in one text, which we will regularly update.

Miscellaneous treatment Educational program coronavirus Special Projects

Read also on ForumDaily:

Coronavirus leads the world to the worst crisis in 100 years: forecast of IMF chief economist

“Such diseases have existed before”: the doctor said why you should not panic because of coronavirus

Can disposable gloves protect against coronavirus: doctors explain

'I seemed to have a piece of meat, not a throat': five stories of people who recovered from COVID-19

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.



1043 requests in 2,139 seconds.